Open AccessP660: SEROLOGIC RESPONSE TO THE SECOND AND THIRD DOSE OF THE SARS‐COV‐2 VACCINE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A PROSPECTIVE, CENTRALIZED, MULTICENTER STUDY.
Author(s) -
Mauro F. R.,
Giannarelli D.,
Galluzzo C.,
Visentin A.,
Frustaci A. M.,
Sportoletti P.,
Vitale C.,
Reda G.,
Gentile M.,
Levato L.,
Murru R.,
Armiento D.,
Ielo C.,
Maglione R.,
Crisanti E.,
Cipiciani A.,
Mattiello V.,
Gianfelici V.,
Barabino L.,
Amici R.,
Coscia M.,
Tedeschi A.,
Trentin L.,
Baroncelli S.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845524.05971.e8
Subject(s) - medicine , chemoimmunotherapy , serology , chronic lymphocytic leukemia , rituximab , immunology , population , vaccination , ighv@ , leukemia , antibody , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom